Mouse Wound Model
Mouse Wound Model - Related Videos
09:20
A Mouse Fetal Skin Model of Scarless Wound Repair
0 Views •
Cited by 24 •
2015
During mammalian development, early gestational skin wounds heal without a scar. Here we detail a reliable and reproducible model of fetal scarless wound healing in the cutaneous dorsum of E16.5 (scarless) and E18.5 (scarring) mouse embryos.
08:35
Demonstration of the Rat Ischemic Skin Wound Model
0 Views •
Cited by 32 •
2015
The rat, due to its size, availability, and rather docile behavior, has been utilized as a research model for many years. The goal of this protocol is to utilize the rat as an ischemic skin wound healing model to provide valuable insight into the pathophysiology of chronic wounds.
05:39
Murine Model of Wound Healing
0 Views •
Cited by 207 •
2013
A murine model of cutaneous wound healing that can be used to assess therapeutic compounds in physiological and pathophysiological settings.
02:20
Generating an Excisional Skin Wound in a Mouse Model via Punch Biopsy
0 Views •
2025
This video demonstrates a punch biopsy procedure to create a precise wound in a mouse model. The excision exposes the subcutaneous layer of the skin, providing a suitable site for studying immune responses to localized pathogen infection.
02:07
Bioluminescence Imaging to Track Bacterial Infection and Wound Healing in a Mouse Model
0 Views •
2026
Source: Hunt, A. M. A., et al. Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model. J. Vis. Exp.(2017).This video demonstrates the procedure for assessing infection clearance and healing progression in a wounded diabetic mouse using bioluminescent and microscopic images.
FAQs
The ordered progression from hemostasis and inflammation to tissue formation and remodeling provides a framework for locating when a treatment acts. Early measurements can indicate effects on inflammatory repair, whereas later assessments reveal changes in tissue formation, vascularization, or remodeling. This timing helps distinguish a material that accelerates closure from one that improves the quality of regenerated tissue.
Outcomes reflect interactions among wound-healing cells, signaling pathways, therapeutic materials, drug-delivery systems, and engineered scaffolds. Changing the material or construct can alter how repair proceeds and can produce differences in closure, re-epithelialization, vascularization, or tissue quality. Controlled injuries allow these factors to be compared systematically rather than evaluated only through uncontrolled changes in wound appearance.
Because the model places a material or scaffold within a living repair response, it can reveal how the intervention interacts with coordinated cellular and signaling processes. This provides information that isolated testing may not capture, including effects on closure, new epithelial coverage, vascularization, and tissue quality. The resulting evidence supports comparison of candidate designs during preclinical development.
A study begins by creating a controlled skin injury, followed by applying or evaluating a selected dressing, drug-delivery system, or tissue-engineered construct. Researchers then monitor repair across the healing process and assess defined outcomes such as closure, re-epithelialization, vascularization, and tissue quality. Comparing treated and control conditions helps attribute differences to the tested intervention.
Wound closure provides a broad measure of repair progress, while re-epithelialization indicates restoration of the skin surface. Vascularization helps evaluate blood-vessel development, and tissue-quality assessments address the character of the repaired region rather than its size alone. Considering these outcomes together gives a more complete interpretation of whether a dressing, delivery system, or scaffold improves healing.
The model connects engineered design with biological performance by allowing researchers to test materials, delivery systems, and scaffolds during tissue repair. It can support mechanistic studies of signaling and cellular responses while also providing preclinical evidence for candidate therapies. However, findings require careful interpretation because biological differences between mice and humans can affect translation to human treatment.